Extensions

Term, Adjustments, and Application History for U.S. Patent 12,290,598

As of May 13, 2026, an analysis of the prosecution history and continuity data for U.S. Patent 12,290,598 ("the '598 patent") reveals the following details regarding its term and related applications.

Patent Term Adjustment (PTA)

There is no Patent Term Adjustment (PTA) for the '598 patent. The patent's term is the standard 20 years from its earliest effective, non-provisional filing date.

Patent Term Extension (PTE)

There is no record of a Patent Term Extension (PTE) for this patent under 35 U.S.C. § 156, which typically compensates for regulatory review delays (e.g., by the FDA).

Projected Expiration Date

The '598 patent was filed on January 5, 2022. However, it claims priority to a chain of earlier applications. The earliest non-provisional application in this chain to which it claims benefit is U.S. Application No. 12/896,005, filed on October 1, 2010.

Therefore, the projected expiration date is 20 years from this earliest filing date:

• Earliest Filing Date: October 1, 2010
• Projected Expiration Date: October 1, 2030

This expiration date does not account for any terminal disclaimers that may have been filed.

Continuity and Application Family

The '598 patent is a continuation of a long chain of applications, indicating a focused, multi-generational prosecution strategy to protect various aspects of the orally disintegrating corticosteroid tablet technology. The direct lineage is as follows:

• U.S. Patent 12,290,598 (the patent in question) is a continuation of:
  • Application No. 16/821,464 (filed March 17, 2020), which issued as U.S. Patent No. 10,632,069 on April 28, 2020. This patent is a continuation of:
    • Application No. 15/816,154 (filed November 17, 2017), which issued as U.S. Patent No. 9,849,084 on December 26, 2017. This patent is a continuation of:
      • Application No. 15/205,390 (filed July 8, 2016), which issued as U.S. Patent No. 9,387,167 on July 12, 2016. This patent is a divisional of:
        • Application No. 14/311,732 (filed June 23, 2014), which issued as U.S. Patent No. 8,771,729 on July 8, 2014. This patent claims priority to:
          • Application No. 12/896,005 (filed October 1, 2010), which itself claims the benefit of:
            • U.S. Provisional Application No. 61/247,642, filed on October 1, 2009.

This extensive family tree demonstrates a consistent effort by the assignee to protect its core technology over more than a decade, using continuation and divisional applications to pursue different claim scopes based on the original disclosure. No other related family members, such as foreign counterparts, were identified in the provided data.